Our client is a dynamic privately held Contract Development & Manufacturing Organization (CDMO) based in Vienna (Austria). The company is offering GMP manufacturing of innovative biopharmaceutical products such as plasmid DNA, messenger RNA, and recombinant proteins to It's international customers which are operating in the ground-breaking fields of vaccine development, personalized tumor therapy, gene therapy and gene editing. With the expansion of a new plant in Vienna by end of 2021, our client is strengthening its position as a mid-sized CDMO on the market.
The future Business Development Manager will be responsible for identifying and developing business opportunities and sales strategies by presenting and promoting our client's contract development & manufacturing services and maintaining a strong understanding of the customer's requirements.
Are you interested in joining a dedicated team within a lean organization? For this full-time position the minimum monthly gross salary according to the applicable collective agreement ("Kollektivvertrag" / KV Handwerk & Gewerbe) amounts to EUR 3.428,19. Depending on your skills and experience, our client offers a higher salary and a performance-oriented bonus.
We are looking forward to receiving your application on our career portal: Our responsible consultant, Mrs. Birgit Wandrak, will get in touch with you after your on-line application. We kindly ask you to support us in handling your application according to the GDPR regulation more effectively and refrain from applying via e-mail.
Ihre Aufgaben: Zielgerichtete und kundenorientierte Planung und Auslegung von biotechnologischen Prozessen und Anlagen, Mitarbeit in internen und/oder externen interdisziplinären Teams, Konzeptionierung...
Ihre Aufgaben: Zielgerichtete und kundenorientierte Planung und Auslegung von biotechnologischen Prozessen und Anlagen, Mitarbeit in internen und/oder externen interdisziplinären Teams, Mitarbeit bei der...
Ihre Aufgaben: Wir agieren als technische Berater für globale Player in der biopharmazeutischen Industrie als auch Start-Ups und KMUs in Mitteleuropa. Zur Erweiterung unseres „Manufacturing Science...